Andrea Ellis
Equibles does not estimate personal net worth.
Get an email with a short summary when BridgeBio Pharma, Inc. publishes a filing, an earnings call transcript or a press release.
Get BBIO alertsAbout Andrea Ellis
Andrea Ellis is recorded as Board Member at BridgeBio Pharma, Inc. (BBIO) since August 17, 2021. BridgeBio Pharma, Inc. reported in an 8-K filed August 23, 2021 that Andrea Ellis was appointed director, effective August 17, 2021. BridgeBio Pharma, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BridgeBio Pharma, Inc. includes Neil Kumar (CEO and Board Member), Charles Homcy (Chairman and Board Member), Brian Stephenson (CFO) and 7 others.
“Effective as of August 17, 2021, the Board, upon the recommendation of the Nominating and Corporate Governance Committee, appointed Fred Hassan, Andrea Ellis and Douglas Dachille to the Board.”
Affiliation history
-
BridgeBio Pharma, Inc. (BBIO)
SEC 8-K
Current2021-08-17–present
-
Current
2021-08-17–present
Company network
Leadership on record at BridgeBio Pharma, Inc.
- Neil Kumar CEO, Board Member
- Charles Homcy Chairman, Board Member
- Brian Stephenson CFO
- Thomas Trimarchi CFO, COO
- Brian Stolz COO
- Brian C. Stephenson Chief Accounting Officer
- Ali J. Satvat Board Member
- Andrea J. Ellis Board Member
- Andrew W. Lo Board Member
- Douglas A. Dachille Board Member